Management of secondary hyperparathyroidism in renal allograft recipients.
D000941:Antigens; D001842:Bone and Bones / Q000473:pathology; D002118:Calcium / Q000097:blood / Q000627:therapeutic use; D003649:Decalcification, Pathologic / Q000175:diagnosis; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D006962:Hyperparathyroidism, Secondary / Q000175:diagnosis / Q000276:immunology / Q000601:surgery*; D016030:Kidney Transplantation; D010026:Osteosclerosis / Q000000981:diagnostic imaging; D010280:Parathyroid Glands / Q000601:surgery*; D010281:Parathyroid Hormone / Q000097:blood; D011859:Radiography; D006435:Renal Dialysis; D013746:Tetany / Q000517:prevention & control; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014511:Uremia / Q000601:surgery; D014807:Vitamin D / Q000627:therapeutic use
D000941:Antigens; D010281:Parathyroid Hormone; D014807:Vitamin D; D006909:Hydroxyproline; D002118:Calcium